Because of these extensive beneficial roles, adiponectin has drawn significant attention to developing it into a therapeutic agent for more effective treatment of the diseases associated with the hormone deficiency such as type 2 diabetes mellitus, obesity, and non-alcoholic steatohepatitis. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.